Skip to content
MedsAcross

Brand family

Omcazio

United States
Presentations
3
Markets
1

Omcazio is a brand of Cabozantinib laurylsulfate marketed by Handa Pharma, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Cabozantinib laurylsulfate
Brand owner
Handa Pharma
Registered in
United States
Strengths and forms
11.5 mg capsule, 23 mg capsule, 34.5 mg capsule

All presentations

MedicineManufacturerRegisterAvailability
Omcazio 11.5 mg capsuleOralHanda PharmaUS FDAAvailable on request
Omcazio 23 mg capsuleOralHanda PharmaUS FDAAvailable on request
Omcazio 34.5 mg capsuleOralHanda PharmaUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Omcazio

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.